Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Cell Therapeutics, Inc
Woman Max 99 years
Cell Therapeutics, Inc
Update Il y a 4 ans
Paclitaxel poliglumex (CT-2103)/Carboplatin vs Paclitaxel/Carboplatin for the Treatment of Chemotherapy-Naive Advanced Non-Small Cell Lung Cancer (NSCLC) in Women with Estradiol > 30 pg/ml
To compare the overall survival of patients randomized to the CT-2103/carboplatin arm to that of patients randomised to the comparator arm (paclitaxel/carboplatin).
Country
None
organs
None
Specialty
None
unknown
More information
Woman Max 99 years
Cell Therapeutics, Inc
Update Il y a 6 ans
Paclitaxel Poliglumex (CT-2103) vs Paclitaxel for the Treatment of Women with Chemotherapy-Naïve Advanced Non-Small Cell Lung Cancer (NSCLC) who are Performance Status 2
The primary objective of this study is to compare the overall survival of female patients randomized to CT-2103 to that of female patients randomized to paclitaxel.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Cell Therapeutics, Inc
Update Il y a 4 ans
A study comparing current standard therapies with pacritinib taken by mouth for the treatment of myelofibrosis (either diagnosed alone or after polycythemia vera or essential thrombocytopenia) in patients with a low platelet count
The primary objective is to compare the efficacy of two dose-schedule arm(s) of pacritinib (pooled once daily [QD] and twice-daily [BID] dosing arms) with that of best available therapy (BAT) in patie...
Country
None
organs
None
Specialty
None
unknown
More information